Parkinson's Disease: Genetics

Parkinson’s disease is a progressive neurodegenerative disorder that affects movement. This feed focuses on genetic screening approaches and genetic predispositions in Parkinson’s disease.

September 14, 2020
Open Access

Understanding the mechanisms of placebo and nocebo effects

Swiss Medical Weekly
Elisa FrisaldiFabrizio Benedetti
September 12, 2020

Vitamin D attenuated 6-OHDA-induced behavioural deficits, dopamine dysmetabolism, oxidative stress, and neuro-inflammation in mice

Nutritional Neuroscience
Adedamola Bayo-OlugbamiBamidele Victor Owoyele
September 16, 2020

Somatic mutations in LRRK2 identify a subset of invasive mammary carcinomas associated with high mutation burden

The American Journal of Pathology
Edgardo R Parrilla CastellarLaurie H Sanders
September 17, 2020
Open Access

Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank

Journal of Neurology, Neurosurgery, and Psychiatry
Benjamin Meir JacobsAlastair J Noyce
September 12, 2020
Review

Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders

Journal of Neurosurgery
Russell R LonserKrystof S Bankiewicz
September 15, 2020

Tacr3/NK3R: Beyond Their Roles in Reproduction

ACS Chemical Neuroscience
Wen-Wen ZhangYu-Xia Chu
September 15, 2020

Alpha-Synuclein Aggregates Associated with Mitochondria in Tunnelling Nanotubes

Neurotoxicity Research
Dario ValdinocciDean L Pountney
September 13, 2020
Open Access

Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation

Neurobiology of Disease
Tomoki KuwaharaTakeshi Iwatsubo
September 11, 2020

Measuring stimulation and inhibition of intracellular nitric oxide production in SIM-A9 microglia using microfluidic single-cell analysis

Analytical Methods : Advancing Methods and Applications
Jay Sibbitts, Christopher T Culbertson
September 15, 2020

Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders

Journal of Alzheimer's Disease : JAD
Matthew John MoldChristopher Exley
September 12, 2020
Open Access

Multiple neuroprotective features of Scutellaria pinnatifida -derived small molecule

Heliyon
Soha ParsafarDina Morshedi
September 12, 2020
Review
Open Access

Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of Neurodegeneration

International Journal of Molecular Sciences
Yulia A Sidorova, Mart Saarma
September 15, 2020

Phosphorylated Alpha-Synuclein Within Cutaneous Autonomic Nerves of Patients With Parkinson's Disease: The Implications of Sample Thickness on Results

The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
Ningshan WangChristopher H Gibbons
September 12, 2020

DNA Methylation as a Potential Molecular Mechanism in X-Linked Dystonia-Parkinsonism

Movement Disorders : Official Journal of the Movement Disorder Society
Christin KrauseHenriette Kirchner

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/parkinsons-disease-genetics/aafce3ab-6d9e-42a4-9fdd-01b8c3f82139